19 Jun, 2013
The Leela Palace, Bengaluru
Home >> Private Equity >>
Wednesday, April 25, 2012 - 13:19 IST
ChrysCapital Invests $56.2M In Intas Pharmaceuticals
BY TEAM VCC
Intas has deferred its IPO where it planned to raise Rs 425cr in fresh capital besides a secondary sale.
Private equity major ChrysCapital is investing Rs 300 crore ($56.2 million) in Ahmedabad-based Intas Pharmaceuticals Ltd, increasing its existing stake of 11.2 per cent in the fast-growing pharma company. With this investment in place,...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Private Equity - Nereus Capital
- Associate - Red Fort Capital Advisors Pvt Ltd
RECENT COMMENTS
- 17 June 2013rj.sridhar@gmail.comonI think it's a bit of a chicken & egg. Is it the combination of some shady promoters plus lack of enough exits...
- 16 June 2013Raj BhattonGoing by the numbers, this values Snowman at 21.7X Mar'13 earnings and 3.5X assets. It is a brilliant pre-IPO...
- 15 June 2013sharad_dalal@hotmail.comonI think this article paints a very distorted picture of a typical PE term sheet. Investment in the form of...
- 14 June 2013SummeeronA candid article Pravin. The situation is indeed piquant. In good companies, where funds fall over each other for the...
UPCOMING EVENTSchinetwork